Keyword Connections

plasminogen

Journals

3

1 journal of aging research

2 journal of cellular physiology

3 tuberculosis (edinburgh, scotland)

Research Groups

0

No Research Group Connected

Bibliographies

31

1 Novel LRAP-binding partner revealing the plasminogen activation system as a regulator of cementoblast differentiation and mineral nodule formation in vitro.

2 uso de rtpa e aspirina no tratamento de trombose intracardíaca em recém-nascido combined rtpa and aspirin therapy for intracardiac thrombosis in neonates

3 lys-plasminogen stimulates vitronectin exposure on the platelet surface

4 plasminogen and fibrinogen plasma levels in coronary artery disease

5 the use of problem-solving therapy for primary care to enhance complex decision-making in healthy community-dwelling older adults

6 Plasminogen, a2-antiplasmin, D-dimer, FX III and plasminogen activator inhibitor in inflammatory bowel disease

7 SMTP-4D, -5D, -6D, -7D and -8D, a new series of the non-lysine-analog plasminogen modulators with a D-amino acid moiety.

8 In vivo ultrasound-activated delivery of recombinant tissue plasminogen activator from the cavity of sub-micrometric capsules.

9 Association between plasminogen activator inhibitor‑1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis : A meta-analysis.

10 Does ICA occlusion frequently have intracerebral hemorrhage after IV tissue plasminogen activator therapy for ischemic stroke?

11 Comparative effects of tissue plasminogen activator, streptokinase, and staphylokinase on cerebral ischemic infarction and pulmonary clot lysis in hamster models.

12 The interaction of streptococcal enolase with canine plasminogen: the role of surfaces in complex formation.

13 Targeted thrombolysis of tissue plasminogen activator and streptokinase with extracellular biosynthesis nanoparticles using optimized Streptococcus equi supernatant.

14 Evaluation of 12-Lipoxygenase (12-LOX) and Plasminogen Activator Inhibitor 1 (PAI-1) as Prognostic Markers in Prostate Cancer

15 Plasminogen activator inhibitor-1 influences cerebrovascular complications and death in pneumococcal meningitis

16 Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy

17 changes of general cerebral symptoms in patients with traumatic brain injury and their dependence on the -675 4g/5g polymorphism in the plasminogen activator inhibitor-1 gene

18 tissue plasminogen activator-assisted vitrectomy for ruptured eye with suprachoroidal hemorrhage

19 plasmid transfer of plasminogen k1-5 reduces subcutaneous hepatoma growth by affecting inflammatory factors

20 analysis of plasminogen genetic variants in multiple sclerosis patients

21 pinocembrin protects blood-brain barrier function and expands the therapeutic time window for tissue-type plasminogen activator treatment in a rat thromboembolic stroke model

22 prothrombotic effect of anti-beta-2 glycoprotein-1 antibodies on the expression of tissue factor, thrombomodulin, and plasminogen activator inhibitor-1 in endothelial cells

23 atividade de plasmina e plasminogênio no leite longa vida com alta e baixa contagem de células somáticas durante o armazenamento activity of plasmin and plasminogen in ultra high temperature milk with high and low somatic cell counts during storage

24 examination of the lipid profile in pregnant obese women, considering the allele status of the genes of angiotensin-converting enzyme (ace i / d) and plasminogen-1 (pa-1 4g / 5g) activator-inhibitor

25 association of tissue mrna and serum antigen levels of members of the urokinase-type plasminogen activator system with clinical and prognostic parameters in prostate cancer

26 clinical value of plasma soluble urokinase-type plasminogen activator receptor levels in term neonates with infection or sepsis: a prospective study

27 intraocular lens opacification following intracameral injection of recombinant tissue plasminogen activator to treat inflammatory membranes after cataract surgery

28 histone deacetylase inhibitor impairs plasminogen activator inhibitor-1 expression via inhibiting tnf-α-activated mapk/ap-1 signaling cascade

29 cytotoxicity of the urokinase-plasminogen activator inhibitor carbamimidothioic acid (4-boronophenyl) methyl ester hydrobromide (bc-11) on triple-negative mda-mb231 breast cancer cells

30 combination low dose tissue type-plasminogen activator plus annexin a2 for improving thrombolytic stroke therapy

31 DNA-Programmed Gold Nanoparticles for Precision Delivery of a Tissue Plasminogen Activator and Thrombin Inhibition in Thrombolytic and Anticoagulant Therapy.